Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | PAR-24-072 | NCI | Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the… More | ||
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) | PAR-23-280 | NCI | The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or… More | ||
| The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional) | PAR-24-117 | NCI | This Notice of Funding Opportunity (NOFO) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More | ||
| NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional) | RFA-EY-24-003 | NEI | The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate translational efforts in developing and implementing accessibility devices or interventions that apply new technologies to… More | ||
| NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) | PAR-21-204 | NEI | The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code… More | ||
| NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) | PAR-23-205 | NEI | The purpose of this NOFO is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders.… More | ||
| NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) | PAR-23-200 | NEI | The purpose of this Notice of Funding Opportunity (NOFO) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual… More | ||
| NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required) | PAR-22-149 | NEI | The NEI uses U01 cooperative agreement awards to support investigator-initiated early-stage clinical trials that are greater than minimal risk and typically are Phase I or II trials. The risk level… More | ||
| NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) | PAR-22-141 | NEI | The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development… More | ||
| NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) | PAR-22-135 | NEI | The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research… More |